Company Description
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally.
The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder.
Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood.
The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
| Country | United States |
| Founded | 2003 |
| IPO Date | Jun 28, 2018 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 203 |
| CEO | Keith Sullivan |
Contact Details
Address: 3222 Phoenixville Pike Malvern, Pennsylvania 19355 United States | |
| Phone | 610 640 4202 |
| Website | neurostar.com |
Stock Details
| Ticker Symbol | STIM |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001227636 |
| CUSIP Number | 64131A105 |
| ISIN Number | US64131A1051 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Keith J. Sullivan | President, Chief Executive Officer and Director |
| Stephen J. Furlong M.S. | Executive Vice President, Chief Financial Officer and Treasurer |
| W. Andrew Macan J.D. | Executive Vice President, GC, Chief Compliance Officer and Corporate Secretary |
| Rusty Page | SVice President and Chief Information and Operations Officer |
| Cory S. Anderson | SVice President and Chief Technology Officer |
| Lisa Metzner-Rosas | Senior Vice President and Chief Marketing Officer |
| Sara Grubbs | Senior Vice President and Chief Revenue Officer |
| William P. Leonard | Chief Clinic Officer |
| Dr. Geoffrey Garland Grammer M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Mar 27, 2025 | 10-K | Annual Report |
| Mar 27, 2025 | PRE 14A | Other preliminary proxy statements |
| Mar 27, 2025 | 8-K/A | [Amend] Current report |
| Mar 4, 2025 | 144 | Filing |
| Mar 4, 2025 | 144 | Filing |
| Mar 4, 2025 | 8-K | Current Report |
| Mar 4, 2025 | 8-K | Current Report |
| Feb 19, 2025 | 144 | Filing |
| Feb 18, 2025 | 144 | Filing |
| Feb 14, 2025 | 144 | Filing |